A big part of Sputnik V vaccine to be produced in India: Kirill Dmitriev, CEO, RDIF
A big part of Sputnik V vaccine will be produced in India. We expect that India will produce up to 850 million doses this year, solving the vaccination issue for India and for the rest of the world, says Kirill Dmitriev, CEO, Russian Direct Investment Fund.
READ MORE:
Other Pharmaceuticals Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma
